We are live on
!
Find out more
THLTP
Thomas H. Lee (THL) Partners Portfolio holdings
AUM
$205M
1-Year Est. Return
1.84%
This Fund
S&P 500
This Quarter
Est. Return
+11.2%
1 Year Est. Return
-1.84%
3 Year Est. Return
-37.17%
5 Year Est. Return
-38.76%
10 Year Est. Return
+21.81%
AUM
$4.37B
AUM Growth
+$1.2B
(+38%)
Cap. Flow
+$1.18B
Cap. Flow
% of AUM
27.12%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
–
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGTI
Agiliti Inc
AGTI
|
+$1.88B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$691M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 50.81% |
| 2 | Industrials | 49.19% |
| 3 | Healthcare | 0% |
Similar funds
MWG
BSHC
MWA
UOMF
AIC
CIG
LIS
BOC
Thomas H. Lee (THL) Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Thomas H. Lee (THL) Partners held 3 positions worth $4.37B, up 38% from $3.16B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Thomas H. Lee (THL) Partners deployed $1.18B of net new capital in Q2 2021, opening 1 new position. Its largest new stake was Agiliti Inc: 98,195,398 shares worth $2.15B.
By sector, the portfolio is most concentrated in Financials at 51% of assets, down from 78% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the most notable exit was Syneos Health, Inc. Class A Common Stock, an estimated $691M sold.
- Thomas H. Lee (THL) Partners's largest Q2 2021 buy was Agiliti Inc: 98,195,398 shares worth $2.15B.
- Thomas H. Lee (THL) Partners fully exited Syneos Health, Inc. Class A Common Stock in Q2 2021, selling an estimated $691M.
- Thomas H. Lee (THL) Partners's ten largest holdings make up 100% of its $4.37B portfolio in Q2 2021.
- Thomas H. Lee (THL) Partners opened 1 new position and closed 1 in Q2 2021.
- Thomas H. Lee (THL) Partners's portfolio value rose 38% quarter-over-quarter to $4.37B.
Based on Thomas H. Lee (THL) Partners's 13F filing for Q2 2021, filed 7 Oct 2021.